Who makes Keluo Xin capsule?

Keluo Xin capsule is developed by Chengdu Kanghong Pharmaceutical Co., Ltd..

What development phase is Keluo Xin capsule in?

Keluo Xin capsule is in Phase 2.

Last reviewed 2026-04-23 · How we verify

Keluo Xin capsule

Chengdu Kanghong Pharmaceutical Co., Ltd. · Phase 2 active Small molecule

At a glance

Generic name	Keluo Xin capsule
Sponsor	Chengdu Kanghong Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Keluo Xin capsule CI brief — competitive landscape report
Keluo Xin capsule updates RSS · CI watch RSS
Chengdu Kanghong Pharmaceutical Co., Ltd. portfolio CI